These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25073833)

  • 1. Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction.
    Chen LS; Baker TB; Piper ME; Smith SS; Gu C; Grucza RA; Smith GD; Munafo M; Bierut LJ
    Drug Alcohol Depend; 2014 Oct; 143():36-43. PubMed ID: 25073833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
    Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
    PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
    Chen LS; Baker TB; Piper ME; Breslau N; Cannon DS; Doheny KF; Gogarten SM; Johnson EO; Saccone NL; Wang JC; Weiss RB; Goate AM; Bierut LJ
    Am J Psychiatry; 2012 Jul; 169(7):735-42. PubMed ID: 22648373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
    Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
    Lee SH; Ahn WY; Seweryn M; Sadee W
    BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.
    Chen LS; Baker TB; Jorenby D; Piper M; Saccone N; Johnson E; Breslau N; Hatsukami D; Carney RM; Bierut LJ
    Drug Alcohol Depend; 2015 Sep; 154():278-82. PubMed ID: 26142345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence.
    Johnson EO; Chen LS; Breslau N; Hatsukami D; Robbins T; Saccone NL; Grucza RA; Bierut LJ
    Addiction; 2010 Nov; 105(11):2014-22. PubMed ID: 20840187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.
    Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ
    Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.
    Chen LS; Baker T; Hung RJ; Horton A; Culverhouse R; Hartz S; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Rosenberger A; Aben KK; Andrew AS; Chang SC; Saum KU; Dienemann H; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden EH; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Brüske I; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare MD; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Amos CI; Bierut LJ
    EBioMedicine; 2016 Sep; 11():219-226. PubMed ID: 27543155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
    Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
    BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
    Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
    Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction.
    Chen LS; Bach RG; Lenzini PA; Spertus JA; Bierut LJ; Cresci S
    Nicotine Tob Res; 2014 Sep; 16(9):1224-31. PubMed ID: 24727484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy.
    Freathy RM; Ring SM; Shields B; Galobardes B; Knight B; Weedon MN; Smith GD; Frayling TM; Hattersley AT
    Hum Mol Genet; 2009 Aug; 18(15):2922-7. PubMed ID: 19429911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
    Chen LS; Hung RJ; Baker T; Horton A; Culverhouse R; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Lutz S; Rosenberger A; Aben KK; Andrew AS; Breslau N; Chang SC; Dieffenbach AK; Dienemann H; Frederiksen B; Han J; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden HF; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Heinrich J; Hokanson JE; Hunter DJ; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare D; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Kraft P; Amos CI; Bierut LJ
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25873736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
    Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ
    Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
    Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interaction.
    Greenbaum L; Rigbi A; Lipshtat N; Cilia R; Tesei S; Asselta R; Djaldetti R; Goldwurm S; Lerer B
    Parkinsonism Relat Disord; 2013 Jan; 19(1):72-6. PubMed ID: 22884254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood adversity increases risk for nicotine dependence and interacts with α5 nicotinic acetylcholine receptor genotype specifically in males.
    Xie P; Kranzler HR; Zhang H; Oslin D; Anton RF; Farrer LA; Gelernter J
    Neuropsychopharmacology; 2012 Feb; 37(3):669-76. PubMed ID: 22012472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers.
    Hartz SM; Short SE; Saccone NL; Culverhouse R; Chen L; Schwantes-An TH; Coon H; Han Y; Stephens SH; Sun J; Chen X; Ducci F; Dueker N; Franceschini N; Frank J; Geller F; Gubjartsson D; Hansel NN; Jiang C; Keskitalo-Vuokko K; Liu Z; Lyytikäinen LP; Michel M; Rawal R; Rosenberger A; Scheet P; Shaffer JR; Teumer A; Thompson JR; Vink JM; Vogelzangs N; Wenzlaff AS; Wheeler W; Xiao X; Yang BZ; Aggen SH; Balmforth AJ; Baumeister SE; Beaty T; Bennett S; Bergen AW; Boyd HA; Broms U; Campbell H; Chatterjee N; Chen J; Cheng YC; Cichon S; Couper D; Cucca F; Dick DM; Foroud T; Furberg H; Giegling I; Gu F; Hall AS; Hällfors J; Han S; Hartmann AM; Hayward C; Heikkilä K; Hewitt JK; Hottenga JJ; Jensen MK; Jousilahti P; Kaakinen M; Kittner SJ; Konte B; Korhonen T; Landi MT; Laatikainen T; Leppert M; Levy SM; Mathias RA; McNeil DW; Medland SE; Montgomery GW; Muley T; Murray T; Nauck M; North K; Pergadia M; Polasek O; Ramos EM; Ripatti S; Risch A; Ruczinski I; Rudan I; Salomaa V; Schlessinger D; Styrkársdóttir U; Terracciano A; Uda M; Willemsen G; Wu X; Abecasis G; Barnes K; Bickeböller H; Boerwinkle E; Boomsma DI; Caporaso N; Duan J; Edenberg HJ; Francks C; Gejman PV; Gelernter J; Grabe HJ; Hops H; Jarvelin MR; Viikari J; Kähönen M; Kendler KS; Lehtimäki T; Levinson DF; Marazita ML; Marchini J; Melbye M; Mitchell BD; Murray JC; Nöthen MM; Penninx BW; Raitakari O; Rietschel M; Rujescu D; Samani NJ; Sanders AR; Schwartz AG; Shete S; Shi J; Spitz M; Stefansson K; Swan GE; Thorgeirsson T; Völzke H; Wei Q; Wichmann HE; Amos CI; Breslau N; Cannon DS; Ehringer M; Grucza R; Hatsukami D; Heath A; Johnson EO; Kaprio J; Madden P; Martin NG; Stevens VL; Stitzel JA; Weiss RB; Kraft P; Bierut LJ
    Arch Gen Psychiatry; 2012 Aug; 69(8):854-60. PubMed ID: 22868939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of the phenotypic and genotypic associations with nicotinic dependence.
    Chen LS; Baker TB; Grucza R; Wang JC; Johnson EO; Breslau N; Hatsukami D; Smith SS; Saccone N; Saccone S; Rice JP; Goate AM; Bierut LJ
    Nicotine Tob Res; 2012 Apr; 14(4):425-33. PubMed ID: 22102629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.